SS Innovations International (NASDAQ:SSII) Downgraded by Wall Street Zen to "Sell"

Key Points

• Analyst downgrade: Wall Street Zen cut SS Innovations International from a "hold" to a "sell," and Weiss Ratings reaffirmed a "sell (e+)," leaving the stock with an average MarketBeat rating of "Sell."
• Weak recent fundamentals: Shares traded around $3.99 while the company reported a quarterly loss (EPS -$0.01), negative return on equity (30.23%) and a negative net margin (-28.54%), with a market cap of about $798.9M.
• Insider buying: Directors Frederic H. Moll and Timothy P. Adams purchased large stakes (501,253 and 300,000 shares) at ~$3.99 on March 6, and insiders bought roughly 1.3M shares (~$5.2M) over the past 90 days.

SS Innovations International (NASDAQ:SSII - Get Free Report) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Saturday.

Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of SS Innovations International in a report on Tuesday, April 21st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of "Sell".

SS Innovations International Stock Down 0.7%

Shares of SSII opened at $3.99 on Friday. The stock has a market cap of $798.92 million and a price-to-earnings ratio of -66.50. SS Innovations International has a 12 month low of $3.02 and a 12 month high of $11.87. The company has a 50-day moving average price of $4.73 and a two-hundred day moving average price of $5.62.

SS Innovations International (NASDAQ:SSII - Get Free Report) last announced its quarterly earnings results on Tuesday, March 10th. The company reported ($0.01) EPS for the quarter. The business had revenue of $14.53 million for the quarter. SS Innovations International had a negative return on equity of 30.23% and a negative net margin of 28.54%.

Insider Transactions at SS Innovations International

In other news, Director Frederic H. Moll acquired 501,253 shares of the company's stock in a transaction dated Friday, March 6th. The stock was bought at an average price of $3.99 per share, with a total value of $1,999,999.47. Following the completion of the acquisition, the director owned 10,775,485 shares in the company, valued at approximately $42,994,185.15. This represents a 4.88% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Timothy P. Adams acquired 300,000 shares of the company's stock in a transaction dated Friday, March 6th. The shares were purchased at an average cost of $3.99 per share, with a total value of $1,197,000.00. Following the acquisition, the director owned 5,331,902 shares of the company's stock, valued at approximately $21,274,288.98. This represents a 5.96% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders bought 1,300,006 shares of company stock valued at $5,196,999.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. PNC Financial Services Group Inc. acquired a new stake in SS Innovations International during the 3rd quarter worth $56,000. Jane Street Group LLC acquired a new stake in SS Innovations International during the 4th quarter worth $63,000. IFC & Insurance Marketing Inc. acquired a new stake in SS Innovations International during the 4th quarter worth $64,000. Goldman Sachs Group Inc. acquired a new stake in SS Innovations International during the 4th quarter worth $68,000. Finally, Envestnet Asset Management Inc. acquired a new stake in SS Innovations International during the 3rd quarter worth $71,000.

About SS Innovations International

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.